← Amgen
Episodes featuring Amgen
64 episodes, newest first.
- Nov 20, 2026
AI valuations collide with inflation and market riskMad Money w/ Jim CramerNov 20, 2026 - Nov 13, 2026
Biotech launches expose the gap between forecasts and adoptionBiotech HangoutNov 13, 2026 - Nov 11, 2026
CoreWeave tests whether AI stocks can sustain their reboundHalftime ReportNov 11, 2026 - Nov 11, 2026
Ro bets healthcare’s future on patient demand and softwareInvest Like the Best with Patrick O'ShaughnessyNov 11, 2026 - Nov 6, 2026
Election stakes meet biotech’s regulatory and pipeline risksBiotech HangoutNov 6, 2026 - Nov 6, 2026
AI’s market reckoning meets jobs, robotics and biotech’s next phaseTBPNNov 6, 2026 - Nov 4, 2026
Markets rally as Democrats take CongressCNBC's "Fast Money"Nov 4, 2026 - Nov 4, 2026
Markets rotate beyond AI as post-midterm rally broadensHalftime ReportNov 4, 2026 - Nov 4, 2026
AI spending strains cash flow as AMD raises the stakesCNBC's "Fast Money"Nov 4, 2026 - Nov 3, 2026
AMD strength meets election risk and data-center backlashClosing BellNov 3, 2026 - Nov 3, 2026
Nasdaq rebound tests market breadth as election risk risesStock Market Today With IBDNov 3, 2026 - Oct 31, 2026
Cramer weighs tech volatility against portfolio diversificationMad Money w/ Jim CramerOct 31, 2026 - Oct 30, 2026
Indexes plunge as investors retreat to cashStock Market Today With IBDOct 30, 2026 - Oct 30, 2026
AI financing fears deepen technology sell-offClosing BellOct 30, 2026 - Oct 30, 2026
AI sell-off tests tech leadership as investors seek safer groundClosing BellOct 30, 2026 - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026 - Oct 30, 2026
Cancer vaccine data meets market volatility at ESMOThe Readout LoudOct 30, 2026 - Oct 29, 2026
Big Tech earnings expose a higher bar for the AI tradeClosing BellOct 29, 2026 - Oct 28, 2026
Apple’s hardware edge meets the bottlenecks of AI’s next phaseTBPNOct 28, 2026 - Oct 27, 2026
U.S. and China rules redraw biotech dealmakingBioCentury This WeekOct 27, 2026 - Oct 26, 2026
Anthropic IPO tests whether AI spending can deliver durable growthHalftime ReportOct 26, 2026 - Oct 26, 2026
Human liver models challenge animal testing in drug developmentBusiness Of BiotechOct 26, 2026 - Oct 23, 2026
Mixed market signals test investors before major earnings weekStock Market Today With IBDOct 23, 2026 - Oct 23, 2026
AI challenges biotech’s old company modelBiotech HangoutOct 23, 2026